Additional file 1 of Clinical and Pharmacoeconomic evaluation of Fidaxomicin in patients over 65 years of age and immunocompromised patients with recurrent and refractory Clostridioides difficile infection
Fields of Study & Subjects
Clostridium difficile and Clostridium perfringens research
Health Systems
Economic Evaluations
Quality of Life
Antibiotic Use and Resistance
Publication details
- Journal / source
- Figshare
- Publication date
- 1 January 2026